Lurker, you seriously shouldn't be investing in biotech stocks as you don't understand the basics of the approval process and to compound it you have your britches in a knot with all the hyperventilating despite b-joshi's comprehensive answer. Maybe you should be investing in indexes and etf's only. Good luck. By the way, they don't make meds with the objective of feeding investor ROI's. med development is strictly for serving the patient community.
Why does Roth estimate the value of RHB-105 at $5/sh to the co. or 50mm if the market for it is 1.5bn and RHB-105 has exclusivity till 2034??? There is currently no direct SOC for H. Pylori infection. Doesn't add up.